person · Reporting owner
Klasko Stephen K. M.D.
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DocGo Inc.DCGO · Entity 7359 | Director | September 10, 2025 | September 11, 2025 |
| Health Assurance Acquisition Corp.HAAC · Entity 122106 | Director | November 12, 2020 | November 12, 2020 |
| TELEFLEX INCTFX · Entity 3798 | Director | May 09, 2025 | May 13, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DocGo Inc.
Report date September 10, 2025 · Filed September 11, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 115,000 |
Reported balance
After 2025-09-10 transaction · row 1
1 source rowRow 1 · 2025-09-10 · Grant · Acquired 100,000 · Balance 115,000 F1: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan") that will vest on September 10, 2026, subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan") that will vest on September 10, 2026, subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.
Health Assurance Acquisition Corp.
Report date November 12, 2020 · Filed November 12, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B common stockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2020-11-12 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: As described in the issuer's registration statement on Form S-1 (File No. 333-249667), as amended, under the heading "Description of Securities-Alignment Shares", the shares of Class B common stock, par value $0.0001, will convert into shares of Class A common stock, par value $0.0001, pursuant to the performance of publicly traded shares of Class A common stock of the issuer after the consummation of the issuer's initial business combination. |
Filing footnotes · ownership attribution and instrument terms
F1: As described in the issuer's registration statement on Form S-1 (File No. 333-249667), as amended, under the heading "Description of Securities-Alignment Shares", the shares of Class B common stock, par value $0.0001, will convert into shares of Class A common stock, par value $0.0001, pursuant to the performance of publicly traded shares of Class A common stock of the issuer after the consummation of the issuer's initial business combination.
TELEFLEX INC
Report date May 09, 2025 · Filed May 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,332.55 |
Reported balance
After 2025-05-09 transaction · row 1
1 source rowRow 1 · 2025-05-09 · Grant · Acquired 1,357 · Balance 9,332.55 F1: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2026 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2025 annual meeting of stockholders. |
| Stock Option / (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $125.11 · Expires 2035-05-09 | Direct | 2,226 |
Reported balance
After 2025-05-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-05-09 · Grant · Acquired 2,226 · Balance 2,226 F2: If the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2026 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2025 annual meeting of stockholders. |
| Common StockSEC Table I · non-derivative | IndirectBy Stephen K. Klasko Revocable Trust | 7,880 |
Reported balance
Holding disclosure · report date 2025-05-09 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 7,880 |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2026 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2025 annual meeting of stockholders.
F2: If the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2026 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2025 annual meeting of stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2017 Filed Dec 4, 2017 23:17 UTC | TELEFLEX INC TFX · Entity 3798 | SaleCommon Stock | 200 | $265.32 | $53,064.00 |
DisclosureSEC source: 0000096943-17-000139 · wf-form4_151242941238783.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| December 01, 2017 Filed Dec 4, 2017 23:17 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionCommon Stock | 200 | $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000139 · wf-form4_151242941238783.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 22:03 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $46.12 Strike: $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000121 · wf-form4_150974659478969.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Underlying: Common Stock · 200 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 22:03 UTC | TELEFLEX INC TFX · Entity 3798 | SaleCommon Stock | 200 | $237.18 | $47,436.00 |
DisclosureSEC source: 0000096943-17-000121 · wf-form4_150974659478969.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 22:03 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionCommon Stock | 200 | $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000121 · wf-form4_150974659478969.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 22:06 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $46.12 Strike: $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000112 · wf-form4_150706839689230.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800 Underlying: Common Stock · 200 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 22:06 UTC | TELEFLEX INC TFX · Entity 3798 | SaleCommon Stock | 200 | $241.88 | $48,376.00 |
DisclosureSEC source: 0000096943-17-000112 · wf-form4_150706839689230.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 22:06 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionCommon Stock | 200 | $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000112 · wf-form4_150706839689230.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 21:04 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $46.12 Strike: $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000107 · wf-form4_150473186847009.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 200 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 21:04 UTC | TELEFLEX INC TFX · Entity 3798 | SaleCommon Stock | 200 | $211.75 | $42,350.00 |
DisclosureSEC source: 0000096943-17-000107 · wf-form4_150473186847009.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 21:04 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionCommon Stock | 200 | $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000107 · wf-form4_150473186847009.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 23:50 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $46.12 Strike: $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000103 · wf-form4_150180421660573.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 Underlying: Common Stock · 200 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 23:50 UTC | TELEFLEX INC TFX · Entity 3798 | SaleCommon Stock | 200 | $208.41 | $41,682.00 |
DisclosureSEC source: 0000096943-17-000103 · wf-form4_150180421660573.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 23:50 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionCommon Stock | 200 | $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000103 · wf-form4_150180421660573.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 22:22 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $46.12 Strike: $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000093 · wf-form4_149929333322896.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 Underlying: Common Stock · 200 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 22:22 UTC | TELEFLEX INC TFX · Entity 3798 | SaleCommon Stock | 200 | $208.10 | $41,620.00 |
DisclosureSEC source: 0000096943-17-000093 · wf-form4_149929333322896.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 22:22 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionCommon Stock | 200 | $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000093 · wf-form4_149929333322896.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:42 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $46.12 Strike: $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000084 · wf-form4_149643972068524.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 Underlying: Common Stock · 200 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:42 UTC | TELEFLEX INC TFX · Entity 3798 | SaleCommon Stock | 200 | $199.93 | $39,986.00 |
DisclosureSEC source: 0000096943-17-000084 · wf-form4_149643972068524.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:42 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionCommon Stock | 200 | $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000084 · wf-form4_149643972068524.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| May 15, 2017 Filed May 16, 2017 21:02 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $46.12 Strike: $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000078 · wf-form4_149496854634435.xml · derivative · entry 7 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 Underlying: Common Stock · 200 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2017 Filed May 16, 2017 21:02 UTC | TELEFLEX INC TFX · Entity 3798 | SaleCommon Stock | 200 | $192.04 | $38,408.00 |
DisclosureSEC source: 0000096943-17-000078 · wf-form4_149496854634435.xml · nonDerivative · entry 5 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2017. Read SEC document |
| May 15, 2017 Filed May 16, 2017 21:02 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionCommon Stock | 200 | $46.12 | $9,224.00 |
DisclosureSEC source: 0000096943-17-000078 · wf-form4_149496854634435.xml · nonDerivative · entry 4 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2017 Filed May 16, 2017 21:02 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionStock Option / (Right to Buy) · Derivative | 5,000 | $56.75 Strike: $56.75 | $283,750.00 |
DisclosureSEC source: 0000096943-17-000078 · wf-form4_149496854634435.xml · derivative · entry 6 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2018-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2017 Filed May 16, 2017 21:02 UTC | TELEFLEX INC TFX · Entity 3798 | SaleCommon Stock | 2,400 | $193.67 | $464,817.60 |
DisclosureSEC source: 0000096943-17-000078 · wf-form4_149496854634435.xml · nonDerivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 Read SEC document |
| May 12, 2017 Filed May 16, 2017 21:02 UTC | TELEFLEX INC TFX · Entity 3798 | SaleCommon Stock | 2,600 | $193.57 | $503,284.60 |
DisclosureSEC source: 0000096943-17-000078 · wf-form4_149496854634435.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,280 Read SEC document |
| May 12, 2017 Filed May 16, 2017 21:02 UTC | TELEFLEX INC TFX · Entity 3798 | Exercise / conversionCommon Stock | 5,000 | $56.75 | $283,750.00 |
DisclosureSEC source: 0000096943-17-000078 · wf-form4_149496854634435.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2017 Filed May 10, 2017 22:17 UTC | TELEFLEX INC TFX · Entity 3798 | GrantStock Option / (Right to Buy) · Derivative | 1,410 | $0.00 Strike: $194.40 | $0.00 |
DisclosureSEC source: 0000096943-17-000067 · wf-form4_149445466541581.xml · derivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,410 Underlying: Common Stock · 1,410 shares Expires 2027-05-09 Read SEC document |
| May 09, 2017 Filed May 10, 2017 22:17 UTC | TELEFLEX INC TFX · Entity 3798 | GrantCommon Stock | 440 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-17-000067 · wf-form4_149445466541581.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,880 F1 · shares: Restricted Stock Award granted pursuant to the Teleflex Incorporated 2014 Stock Incentive Plan. Shares vest on November 9, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.